Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 64 citing Davies: The prevalence, severity, and impact of painful diabetic peripheral neuropathy in.... (0.15 sec) 

The impact of neuropathic pain on health-related quality of life: review and implications


MP Jensen, MJ Chodroff, RH Dworkin - Neurology, 2007 - AAN Enterprises
A number of high-quality studies have recently been published that examine the
association between neuropathic pain and health-related quality of life (HRQoL).
The current review identified 52 such studies in patients with six ...
Cited by 44 - Related articles - All 5 versions

Prevalence of chronic pain with neuropathic characteristics in the general population

- archives-ouvertes.fr [PDF] 
D Bouhassira, M Lantéri-Minet, N Attal, B … - Pain, 2008 - Elsevier
We conducted a large nationwide postal survey to estimate the prevalence of
chronic pain with or without neuropathic characteristics in the French general
population. A questionnaire aimed at identifying chronic pain (defined as ...
Cited by 35 - Related articles - All 29 versions

New perspectives on the management of diabetic peripheral neuropathic pain

- dvdres.co.uk [PDF] 
TS Jensen, MM Backonja, SH Jimenez, S … - Diabetes & Vascular Disease Research, 2006 - dvr.sagepub.com
Abstract P eripheral neuropathy affects about 30% of people with diabetes
mellitus. Between 16% and 26% of diabetes patients experience chronic pain. This
may be referred to as diabetic neuropathic pain (DNP) or dia- betic ...
Cited by 26 - Related articles - BL Direct - All 9 versions

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral …

- nih.gov - Free from Publisher
R Freeman, E Durso-DeCruz, B Emir - Diabetes Care, 2008 - Am Diabetes Assoc
RESULTS—Pooled analysis showed that pregabalin significantly reduced pain and
pain-related sleep interference associated with DPN (150, 300, and 600 mg/day
administered TID vs. placebo, all P ≤ 0.007). Only the 600 mg/day dosage ...
Cited by 19 - Related articles - All 9 versions

Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral …


D Ziegler, YL Pritchett, F Wang, D Desaiah, … - Diabetes care, 2007 - Am Diabetes Assoc
RESULTS—There were no significant (P > 0.10) interactions of treatment by age
(<65 or ≥65 years), type of diabetes (type 1 or type 2), duration of diabetes
(median split <9.18 or ≥9.18 years), duration of diabetic neuropathy (<2, ...
Cited by 17 - Related articles - BL Direct - All 6 versions

Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia


M Romiti, M Albers, FC Brochado-Neto, AES … - Journal of Vascular Surgery, 2008 - Elsevier
Percutaneous transluminal angioplasty has been used with increasing frequency in
the treatment of infrainguinal arterial occlusive disease. This meta-analysis
aimed to assess the middle-term outcomes after crural angioplasty in ...
Cited by 13 - Related articles - All 45 versions

A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic …


A Sadosky, AM McDermott, NA Brandenburg, … - Pain Practice, 2008 - pt.wkhealth.com
Abstract: Although the burden of neuropathic pain is well-recognized, the
descriptive epidemiology of specific neu- ropathic pain conditions has not been
well-described. While painful diabetic peripheral neuropathy and ...
Cited by 11 - Related articles - BL Direct - All 4 versions

Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered …

- diabetesjournals.org
S Tesfaye, R Tandan, EJ Bastyr, KA Kles, V … - Diabetes Care, 2007 - Am Diabetes Assoc
RESULTS—After 1 year, change in the neuropathy impairment score of lower limbs
[NIS(LL)] (−0.63 points; P = 0.005), vibration detection threshold (VDT)
(−0.42 just noticeable difference units; P = 0.003), and Neuropathy Total ...
Cited by 9 - Related articles - BL Direct - All 4 versions

Painful diabetic neuropathy: treatment and future aspects


D Ziegler - Diabetes/Metabolism Reviews - interscience.wiley.com
Around one of three diabetic patients is affected by distal symmetric
polyneuropathy (DSP) which represents a major health problem, as it may present
with partly excruciating neuropathic pain and is responsible for ...
Cited by 9 - Related articles - BL Direct - All 3 versions

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial

- co-orthopaedics.com
RY Yuan, JJ Sheu, JM Yu, WT Chen, IJ … - Neurology, 2009 - AAN Enterprises
Background: Diabetic neuropathy is a common complication in diabetes, with
patients typically experiencing diverse sensory symptoms including dysesthesias
in the feet and usually accompanied by sleep disturbance. There is still no ...
Cited by 7 - Related articles - All 7 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google